AITechFundingNewsabout 1 hour ago
CriteriaCaixa targets €300M for AI and biotech
3 min read
CriteriaCaixa renamed its venture arm Criteria Capital Risc and targets €300 million in early-stage biotech and deeptech investment by 2030. The capital runs through two evergreen funds backing biotech, AI, photonics, cybersecurity, and software infrastructure. Nearly 70% of the current portfolio is held in Spanish companies.
Level
Hype check
Tap to vote and see what everyone thinks.
In this storyArm
Summary by ByteBrief
